SYS6017

· CSPC Megalith Biopharmaceutical Co.,Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SYS6017, covering 2025-05-08 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of SYS6017 in the Participants Aged 40 Years and Above [Phase 2]